>cd05169 PIKKc_TOR TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. TOR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). TOR contains a rapamycin binding domain, a catalytic domain, and a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. It is also called FRAP (FK506 binding protein 12-rapamycin associated protein). TOR is a central component of the eukaryotic growth regulatory network. It controls the expression of many genes transcribed by all three RNA polymerases. It associates with

Probab=92.66  E-value=0.093  Score=32.79  Aligned_cols=27  Identities=30%  Similarity=0.587  Sum_probs=23.3

Q ss_pred             EECCCCCCCEEEEE-CCCCEEEEECCHH
Q ss_conf             66178786228980-2895357434031
Q gi|254780623|r  283 FFHADLHPGNLFVD-SKGYIVAVDMGIT  309 (517)
Q Consensus       283 fFHaDPHpGNi~v~-~dg~i~~lDfG~v  309 (517)
T Consensus       183 lGlGDRH~~NILi~~~tG~vvHIDFg~~  210 (280)
T cd05169         183 LGLGDRHPSNIMIDRLTGKVIHIDFGDC  210 (280)
T ss_pred             EECCCCCCCCEEEECCCCCEEEEECHHH
T ss_conf             1316898643799868787899841665